What are microbiological effects of the adjunctive use of probiotics in the treatment of periodontal diseases? A systematic review
- 30 August 2021
- journal article
- review article
- Published by Brill in Beneficial Microbes
- Vol. 12 (4), 307-319
- https://doi.org/10.3920/bm2020.0143
Abstract
Probiotics have aroused great interest as an adjunctive treatment to periodontal therapy, due to the frequent colonisation by periodontopathogens after therapy. The aim of this systematic review was to analyse in the scientific literature, evidence of the microbiological effects of probiotics as an adjunct to periodontal therapy in the treatment of periodontal diseases (PD). Only randomised controlled trials (RCT), evaluating the microbiological effect of probiotics as an adjunct to periodontal therapy. The authors conducted a search in PubMed/MEDLINE, LILACS, ScienceDirect, Web of Science and Cochrane Library to identify articles published in English until February 2020. The quality of the studies was assessed using the JADAD scale and the risk of bias was assessed according to the Cochrane Collaboration assessment tool. Of the 265 articles potentially relevant to this review, 10 studies were included. The most frequently used probiotic bacteria were those of the genus Lactobacillus spp. and the time of administration of the probiotics was between 14 days to 3 months. Most studies have shown that the adjuvant use of probiotics reduces the total mean counts of gram-negative anaerobic species (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola and Prevotella intermedia) and gram-negative coccobacillus (Aggregatibacter actinomycetemcomitans) of subgingival plaque samples. Probiotics adjuvant to periodontal therapy reduces periodontopathogenic species in a greater proportion, compared only to periodontal therapy. Especially the Lactobacillus reuteri strain, without combination with other strains, offered a greater reduction in pathogenic bacteria associated with greater destruction of periodontal tissues and deep periodontal pockets. Researchers should perform high-quality RCT, evaluating single strains without combinations, in order to observe the microbiological benefits as adjunctive treatment of PD.Keywords
This publication has 45 references indexed in Scilit:
- Evaluation of the Effect of Probiotic (Inersan®) Alone, Combination of Probiotic with Doxycycline and Doxycycline Alone on Aggressive Periodontitis – A Clinical and Microbiological StudyJournal of Clinical and Diagnostic Research, 2013
- Probiotics and Oral HealthCurrent Pharmaceutical Design, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in miceBMC Microbiology, 2011
- Do probiotics offer opportunities to manipulate the periodontal oral microbiota?Journal of Clinical Periodontology, 2011
- Biological approaches to the development of novel periodontal therapies – Consensus of the Seventh European Workshop on PeriodontologyJournal of Clinical Periodontology, 2011
- Effect of the probioticLactobacilli reuteri(Prodentis) in the management of periodontal disease: a preliminary randomized clinical trialJournal of Oral Microbiology, 2010
- Microbial Interactions Influence Inflammatory Host Cell ResponsesJournal of Dental Research, 2009
- Modulation of clinical expression of plaque‐induced gingivitisJournal of Clinical Periodontology, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996